Multivalent alteration of quorum sensing in Staphylococcus aureus. 2013

Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Virulence in Staphylococcus aureus is strongly and positively correlated with local cell density. Here we present an effective approach to modulate this group behaviour using multivalent peptide-polymer conjugates. Our results show that by attaching multiple AIP-4' units to macromolecular scaffolds, the agr QS response in S. aureus was affected strongly, while displaying a clear multivalency effect.

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D053038 Quorum Sensing A phenomenon where microorganisms communicate and coordinate their behavior by the accumulation of signaling molecules. A reaction occurs when a substance accumulates to a sufficient concentration. This is most commonly seen in bacteria. Quorum Quenching,Quenching, Quorum,Quenchings, Quorum,Quorum Quenchings,Sensing, Quorum

Related Publications

Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
March 2004, Journal of bacteriology,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
January 2023, Arerugi = [Allergy],
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
January 2013, mBio,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
January 2010, Nature chemical biology,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
March 2014, Infection and immunity,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
May 2018, Cell host & microbe,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
April 2015, Antimicrobial agents and chemotherapy,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
June 2003, FEMS microbiology letters,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
January 2011, Planta medica,
Sarit Melamed Yerushalmi, and Maren E Buck, and David M Lynn, and N Gabriel Lemcoff, and Michael M Meijler
October 2009, Journal of microbiology (Seoul, Korea),
Copied contents to your clipboard!